product summary
Loading...
company name :
HUABIO
product type :
antibody
product name :
NK1.1
catalog :
HA751221
quantity :
100μl
price :
649.00 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
PSH08-46
reactivity :
mouse
application :
flow cytometry
more info or order :
image
image 1 :

Flow cytometric analysis of C57BL/6 mouse spleen cells labeling NK1.1.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA751221, 1/400). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 594 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1122) at 1/1,000 dilution for 30 minutes at +4℃.
product information
SKU :
HA751221
Target name :
NK1.1
Species reactivity :
Mouse
Applications :
FC
Conjugate :
Non-conjugated
Immunogen :
Recombinant protein within mouse NK1.1 aa 67-223.
Uniprot id :
P27814>SwissProt: P27814 Mouse
Host :
Rabbit
Clone number :
PSH08-46
Isotype :
IgG
Size :
100μl
List Price :
649.00 USD
Storage Buffer :
PBS (pH7.4).
Form :
Liquid
Storage Instruction :
Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Purity :
Protein A affinity purified.
Product type :
Recombinant Rabbit monoclonal Antibody
Positive control :
C57BL/6 mouse spleen cells.
Molecular wt :
Predicted band size: 25 kDa
Subcellular location :
Membrane
Concentration :
1 mg/mL.
Recommended dilutions :
FC: 1:400
more info or order :
company information

HUABIO
Founded in 2007, HUABIO is dedicated to developing high-quality antibodies that advance innovation. We are passionate about the accuracy, efficiency, and consistency of our products. That is why we have invested in new production platforms, like recombinant rabbit monoclonals, alpaca nanobodies, and adopted aggressive QA standards to deliver cutting-edge antibodies with uncompromised quality.
We hope to see you at your next discovery!
We hope to see you at your next discovery!
related products
browse more products
questions and comments
